drug development Related News
World-first study finds drug to halt dementia after head injuries
Scientists have identified a drug to halt the development of dementia in athletes who have sustained multiple head injuries.
In the world-first international study, researchers...
VAZKEPA® (icosapent ethyl): Revolutionising cardiovascular disease treatment
Dr. Craig Granowitz, the Chief Medical Officer of pharmaceutical company Amarin Corporation, speaks to Health Europa about the never-ending pandemic, the number one cause...
Cutting the fuel supply to cells can prevent cancer spreading
Halting the energy supply to certain cells can help to stop the spread of cancer, researchers have discovered.
A study by scientists from the Translational...
Digital tool will reduce the cost of developing new medicines
A new digital tool is being rolled out in the UK that will make developing medicines cheaper, safer, and faster.
In a vital step for...
Major progress made to improve Parkinson’s disease treatment
Scientists have made a breakthrough in the development of a nasal spray for Parkinson’s disease treatment.
Researchers from the University of York have developed a...
Improving COVID-19 patient outcomes with monoclonal antibodies
A study in the US has concluded that a COVID-19 monoclonal antibodies treatment significantly mitigates the risk of hospitalisation and death from the disease.
The...
Combatting acute pancreatitis with new monoclonal antibody
A phase two global study has confirmed that the investigational drug evinacumab can successfully reduce triglycerides in patients with acute pancreatitis.
The study, led by...
Commonly used anaesthetic may influence Alzheimer’s disease pathology
A novel investigation has indicated that a commonly used anaesthetic may influence brain proteins that stimulate Alzheimer’s disease pathology.
The study, conducted by researchers at...
Study suggests the immune system triggers the effects of psychosis
Novel research has indicated a correlation between genetic changes that influence the brain’s immune system and psychosis, potentially advancing treatments.
The study, conducted by researchers...
World-first major progressive multiple sclerosis trial to launch in UK
The world’s first meg-trial for progressive multiple sclerosis (MS) is to launch later this year in the UK.
The Octopus trial is a revolutionary clinical...
MHRA gives green light to cardiovascular treatment
The Medicines and Healthcare products Regulatory Agency has authorised Vazkepa to reduce cardiovascular risk in statin-treated adult patients who have elevated triglycerides and other...
R21/Matrix-M malaria vaccine becomes first to reach 75% efficacy target
R21/Matrix-M has become the first malaria vaccine ever to achieve the World Health Organization’s 75% efficacy goal after being confirmed by a Phase IIb...
UK to roll out innovative at home COVID-19 treatments
The UK Government is to roll out innovative COVID-19 treatments for patients to use at home in order to mitigate the spread of the...
Chemical biomarker detects severe COVID-19 symptoms
The novel discovery of a chemical biomarker that indicates the severity of COVID-19 symptoms could help to improve patient treatments.
The research, conducted by medical...
Managing early-stage COVID-19 with repurposed drugs
A large-scale human genetic study has been used to identify drug targets that could help manage COVID-19 progression in the early stages of the...
Ribosomes offer the potential for new antibiotics
Researchers are hoping to exploit the processes of ribosomes for the development of novel antibiotic agents.
Ribosomes are an essential component of all living cells,...
Single cell sequencing technology could find drugs that eradicate cancer
Researchers have developed a new sequencing method that could boost international research efforts to find drugs that could eradicate cancer.
The single cell sequencing method,...
Protein kinase inhibitors could offer a new HIV treatment option
A new study shows that protein kinases, enzymes that initiate the process that erodes the body’s immunity, are partly responsible for immunodeficiency in HIV patients. The findings will help explore new treatment options for the condition.
Substance could help develop Alzheimer’s medications
Scientists have confirmed that a common spasmolytic drug can suppress neuroinflammation and could lead to the development of medications against Alzheimer’s Disease.
A team of...
Positive opinion for hereditary angioedema medicine for use in patients over 12
The Committee for Medicinal Products for Human Use (CHMP) has recommended the medicine berotralstat for the routine prophylaxis of hereditary angioedema in patients aged...